| 000 | 01730 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518085957.0 | ||
| 264 | 0 | _c20210802 | |
| 008 | 202108s 0 0 eng d | ||
| 022 | _a1544-2241 | ||
| 024 | 7 |
_a10.1007/s11914-020-00566-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCurtis, Elizabeth M | |
| 245 | 0 | 0 |
_aGeneral and Specific Considerations as to why Osteoporosis-Related Care Is Often Suboptimal. _h[electronic resource] |
| 260 |
_bCurrent osteoporosis reports _c02 2020 |
||
| 300 |
_a38-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAbsorptiometry, Photon |
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xetiology |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Competence |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aFemoral Fractures _xchemically induced |
| 650 | 0 | 4 | _aGuideline Adherence |
| 650 | 0 | 4 | _aHealth Knowledge, Attitudes, Practice |
| 650 | 0 | 4 | _aHealth Policy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMultimorbidity |
| 650 | 0 | 4 |
_aOsteoporosis _xdiagnosis |
| 650 | 0 | 4 |
_aOsteoporotic Fractures _xprevention & control |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPrimary Prevention |
| 650 | 0 | 4 | _aQuality of Health Care |
| 650 | 0 | 4 | _aReimbursement Mechanisms |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSecondary Prevention |
| 700 | 1 | _aWoolford, Stephen | |
| 700 | 1 | _aHolmes, Claire | |
| 700 | 1 | _aCooper, Cyrus | |
| 700 | 1 | _aHarvey, Nicholas C | |
| 773 | 0 |
_tCurrent osteoporosis reports _gvol. 18 _gno. 1 _gp. 38-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11914-020-00566-7 _zAvailable from publisher's website |
| 999 |
_c30677948 _d30677948 |
||